Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

In the next couple of days, APC’s 2023 Compounder Profile Survey will land in the email boxes of more than 8,000 compounding professionals, including yours.

It’s an important survey. Please take time to complete it.

With our research partners at the University of Utah School of Pharmacy, APC will use the results of this every-other-year survey to produce our “Snapshot of Pharmacy Compounding in America 2023,” along with a detailed report, the “2023 National Pharmacy Compounding Demographics Study.”

Details about the wide use of pharmacy compounding have been hard to come by in recent years. This survey and the resulting reports will provide some definition for the profession here and now — how it’s structured, what compounders are doing in their businesses, and yes, what are the challenges you’re facing.

The 2023 Snapshot of Pharmacy Compounding will also be shared in meetings with members of Congress and other policy makers to help them better understand your profession.

So, watch for the link to the survey coming soon, and don’t ignore or lose it. Note: It will be sent from University of Utah College of Pharmacy, and the actual email address is surveys@qualtrics-research.com. Be sure to check your spam folder if you don’t receive it soon.

Please complete the survey so that we have the best, most robust data set possible.